Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Sekisui Chemical

エスケー化研

大正製薬ホールディングス

Kuraray

持田製薬

The Nippon Synthetic Chemical Industry

ダイセル

Fuso Pharmaceutical Industries

NIPPON KAYAKU

Mitsubishi Tanabe Pharma

JSR

Takeda Pharmaceutical

Nissan Chemical Industries

NIPPON PAINT

中外製薬

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

日本セラミック

日本セラミック

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: The Nippon Synthetic Chemical Industry (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: The Nippon Synthetic Chemical Industry (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	0.91% (-12.05%)	6.38% (-0.50%)	6.71% (1.53%)	3.61% (-1.67%)	8.86% (3.05%)
C/F margin (Industry Average)	7.32% (-3.31%)	20.28% (8.51%)	15.48% (7.04%)	10.57% (6.35%)	17.79% (8.25%)
ROA (Industry Average)	0.86% (0.52%)	5.39% (1.04%)	6.26% (2.07%)	3.16% (0.06%)	7.27% (2.71%)
ROE (Industry Average)	1.89% (-1.43%)	10.65% (0.03%)	11.15% (2.96%)	5.63% (4.68%)	12.46% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	11.04% (5.01%)	1.78% (2.61%)	1.90% (-0.40%)	16.87% (8.16%)
Sales growth (Industry Average)	- (-)	-10.77% (-2.67%)	1.30% (5.36%)	-4.40% (1.07%)	5.42% (2.24%)
Net profit growth (Industry Average)	- (-)	523.29% (203.46%)	6.57% (63.25%)	-48.55% (3.89%)	158.65% (90.38%)
Operating C/F growth (Industry Average)	- (-)	147.05% (275.10%)	-22.65% (35.09%)	-34.73% (-6.09%)	77.43% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	45.51% (53.80%)	50.59% (54.51%)	56.15% (55.00%)	56.13% (53.59%)	58.33% (56.30%)
Liquidity ratio (Industry Average)	148.83% (217.72%)	183.37% (225.70%)	187.28% (237.55%)	174.85% (239.89%)	172.11% (236.21%)
C/F ratio current liabilities (Industry Average)	467.75% (777.21%)	162.80% (303.31%)	184.00% (434.79%)	306.72% (929.73%)	202.55% (573.30%)
Quick ratio (Industry Average)	79.88% (138.97%)	116.82% (148.85%)	118.95% (156.17%)	102.83% (160.84%)	101.22% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	68.24day (83.89day)	100.66day (94.27day)	91.57day (93.96day)	101.30day (97.92day)	99.68day (98.27day)
Inventory turnover (Industry Average)	73.11day (54.45day)	63.95day (52.58day)	62.68day (52.64day)	73.33day (56.59day)	78.52day (58.68day)
Payable turnover (Industry Average)	43.52day (45.01day)	56.98day (49.82day)	54.68day (49.52day)	61.28day (52.10day)	63.56day (51.12day)
Working capita turnover (Industry Average)	97.83day (93.32day)	107.63day (97.02day)	99.58day (97.08day)	113.34day (102.41day)	114.64day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	131.29% (34.57%)	-20.21% (1.49%)	-0.78% (-3.85%)	64.83% (21.16%)
Dividend Yield (Industry Average)	3.31% (3.20%)	1.94% (1.93%)	3.57% (2.17%)	2.73% (2.45%)	1.54% (2.07%)
PER (Industry Average)	29.62% (25.22%)	10.99% (23.06%)	8.23% (16.22%)	15.87% (29.19%)	10.11% (16.58%)
PBR (Industry Average)	0.56% (0.86%)	1.17% (1.06%)	0.91% (1.04%)	0.89% (0.95%)	1.26% (1.08%)
PCFR (Industry Average)	3.69% (7.18%)	3.46% (9.23%)	3.57% (-2.43%)	5.42% (9.50%)	5.04% (7.56%)
PSR (Industry Average)	0.27% (0.77%)	0.70% (0.88%)	0.55% (1.10%)	0.57% (0.90%)	0.89% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	0.66% (-27.66%)	8.18% (-4.34%)	6.44% (-5.37%)	1.62% (-10.69%)	8.47% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	0.44% (0.52%)	5.74% (0.92%)	4.46% (1.42%)	1.05% (-0.27%)	5.66% (1.53%)
ROE (Industry Average)	0.80% (-0.84%)	9.80% (-0.46%)	6.96% (1.81%)	1.69% (3.42%)	8.83% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	8.67% (3.64%)	5.00% (3.03%)	-0.63% (0.04%)	7.84% (3.91%)
Sales growth (Industry Average)	- (-)	6.86% (-3.48%)	-5.28% (6.70%)	-4.00% (0.75%)	7.73% (-1.74%)
Net profit growth (Industry Average)	- (-)	1,217.86% (166.48%)	-25.47% (43.48%)	-75.75% (-47.04%)	461.14% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	54.82% (56.79%)	58.56% (57.65%)	64.09% (57.17%)	62.03% (55.93%)	64.04% (57.57%)
Liquidity ratio (Industry Average)	171.53% (337.22%)	213.38% (276.75%)	195.80% (266.94%)	161.54% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	87.43% (167.28%)	131.16% (183.78%)	120.15% (174.83%)	91.66% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	67.35day (87.55day)	104.54day (98.39day)	99.67day (95.88day)	112.38day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	79.65day (50.17day)	64.81day (48.43day)	71.83day (47.43day)	85.33day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	34.34day (45.70day)	49.03day (51.63day)	49.94day (51.13day)	58.29day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	112.66day (92.02day)	120.32day (95.19day)	121.56day (92.19day)	139.41day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	131.29% (34.46%)	-20.21% (3.11%)	-0.78% (-3.30%)	64.83% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	72.92% (34.12%)	12.79% (27.80%)	13.70% (13.58%)	56.06% (22.26%)	16.46% (26.42%)
PBR (Industry Average)	0.58% (0.97%)	1.25% (1.21%)	0.95% (1.17%)	0.95% (1.08%)	1.45% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.48% (3.42%)	1.04% (4.34%)	0.88% (3.67%)	0.91% (4.37%)	1.39% (10.14%)

Financial Indicator Details: The Nippon Synthetic Chemical Industry

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	0.91%	6.38%	6.71%	3.61%	8.86%
C/F margin	7.32%	20.28%	15.48%	10.57%	17.79%
ROA	0.86%	5.39%	6.26%	3.16%	7.27%
ROE	1.89%	10.65%	11.15%	5.63%	12.46%
Recurring margin	2.05%	11.11%	10.36%	7.75%	13.45%
EBIT margin	2.97%	11.36%	10.53%	6.33%	13.99%
EBITDA margin	9.77%	18.88%	17.81%	13.90%	21.52%
NOPAT margin	1.78%	6.81%	6.32%	3.80%	8.39%
Sales SG rates	81.91%	73.08%	73.76%	75.61%	71.01%
Sales SG&A rates	13.74%	14.96%	15.17%	16.23%	16.09%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	6.79%	7.52%	7.28%	7.56%	7.53%
Capital expenditures net sales ratio	-3.90%	-5.35%	-6.46%	-9.20%	-11.71%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	13.09%	-18.89%	-39.28%	72.84%
Equity growth	-	11.04%	1.78%	1.90%	16.87%
Total assets growth	-	-0.11%	-8.28%	1.94%	12.44%
Sales growth	-	-10.77%	1.30%	-4.40%	5.42%
Net profit growth	-	523.29%	6.57%	-48.55%	158.65%
Operating C/F growth	-	147.05%	-22.65%	-34.73%	77.43%
Recurring profit growth	-	383.67%	-5.51%	-28.50%	82.98%
EBIT growth	-	241.16%	-6.06%	-42.46%	132.65%
EBITDA growth	-	72.42%	-4.41%	-25.40%	63.26%
NOPAT growth	-	241.16%	-6.06%	-42.46%	132.65%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	45.51%	50.59%	56.15%	56.13%	58.33%
Liquidity ratio	148.83%	183.37%	187.28%	174.85%	172.11%
C/F ratio current liabilities	467.75%	162.80%	184.00%	306.72%	202.55%
Quick ratio	79.88%	116.82%	118.95%	102.83%	101.22%
Fixed ratio	93.31%	82.06%	75.32%	77.56%	74.50%
D/E ratio	66.24%	42.06%	24.68%	21.33%	15.33%
Loan to Value Ratio	30.14%	21.28%	13.86%	11.97%	8.94%
Business investment C/F ratio	-53.36%	-26.40%	-41.74%	-87.04%	-65.82%
Liabilities with interest growth	-	-29.48%	-40.25%	-11.92%	-16.02%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	31.67day	40.14day	32.14day	20.41day	33.46day
Receivables turnover	68.24day	100.66day	91.57day	101.30day	99.68day
Inventory turnover	73.11day	63.95day	62.68day	73.33day	78.52day
Fixed assets turnover	164.02day	179.51day	165.55day	181.72day	193.50day
Total asset turnover	386.17day	432.29day	391.38day	417.37day	445.17day
Payable turnover	43.52day	56.98day	54.68day	61.28day	63.56day
Capital turnover	65.03day	72.88day	71.94day	75.26day	71.38day
Equity turnover	175.76day	218.73day	219.77day	234.27day	259.70day
Working capita turnover	97.83day	107.63day	99.58day	113.34day	114.64day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 8 B	¥ 9 B	¥ 8 B	¥ 4 B	¥ 8 B
Accounts receivable-trade	¥ 18 B	¥ 24 B	¥ 22 B	¥ 24 B	¥ 25 B
Other Current Assets	¥ 42 B	¥ 44 B	¥ 40 B	¥ 44 B	¥ 48 B
Current Assets	¥ 51 B	¥ 54 B	¥ 48 B	¥ 49 B	¥ 57 B
Tangible Assets	¥ 45 B	¥ 44 B	¥ 41 B	¥ 43 B	¥ 48 B
Intangible Assets	¥ 1 B	¥ 900 M	¥ 839 M	¥ 665 M	¥ 489 M
Investment etc.	¥ 8 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 5 B
Total Assets	¥ 106 B	¥ 106 B	¥ 97 B	¥ 99 B	¥ 112 B
Current Liabilities	¥ 34 B	¥ 29 B	¥ 26 B	¥ 28 B	¥ 33 B
Fixed Liabilities	¥ 23 B	¥ 22 B	¥ 16 B	¥ 15 B	¥ 13 B
Liabilities with interest	¥ 32 B	¥ 22 B	¥ 13 B	¥ 11 B	¥ 10 B
Net Assets	¥ 48 B	¥ 53 B	¥ 54 B	¥ 55 B	¥ 65 B
Capital stock	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B
Capital surplus etc.	¥ 30 B	¥ 35 B	¥ 36 B	¥ 38 B	¥ 47 B
Liabilities and net assets	¥ 106 B	¥ 106 B	¥ 97 B	¥ 99 B	¥ 112 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 100 B	¥ 90 B	¥ 91 B	¥ 87 B	¥ 91 B
Cost of Sales	¥ 82 B	¥ 65 B	¥ 67 B	¥ 65 B	¥ 65 B
Gross profit	¥ 18 B	¥ 24 B	¥ 23 B	¥ 21 B	¥ 26 B
Other income	¥ 749 M	¥ 497 M	¥ 491 M	¥ 376 M	¥ 1 B
SG&A	¥ 13 B	¥ 13 B	¥ 13 B	¥ 14 B	¥ 14 B
Other expenses	¥ 3 B	¥ 5 B	¥ 3 B	¥ 4 B	¥ 5 B
Net income	¥ 923 M	¥ 5 B	¥ 6 B	¥ 3 B	¥ 8 B
Operating income	¥ 4 B	¥ 10 B	¥ 10 B	¥ 7 B	¥ 11 B
Ordinary Income	¥ 2 B	¥ 10 B	¥ 9 B	¥ 6 B	¥ 12 B
EBITDA	¥ 9 B	¥ 17 B	¥ 16 B	¥ 12 B	¥ 19 B
Income before income taxes	¥ 2 B	¥ 9 B	¥ 9 B	¥ 5 B	¥ 12 B
Depreciation	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 869 M	¥ 3 B	¥ 2 B	¥ 2 B	¥ 4 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 7 B	¥ 18 B	¥ 14 B	¥ 9 B	¥ 16 B
Investment CF	¥ -4 B	¥ -4 B	¥ -7 B	¥ -8 B	¥ -10 B
Financial CF	¥ -2 B	¥ -10 B	¥ -9 B	¥ -2 B	¥ -3 B
Foreign Exchange Effects	¥ -549 M	¥ -23 M	¥ -329 M	¥ -142 M	¥ 425 M
Net Change in Cash	¥ -706 M	¥ 3 B	¥ -3 B	¥ -2 B	¥ 2 B
Free CF	¥ 2 B	¥ 13 B	¥ 6 B	¥ 648 M	¥ 5 B
Capital expenditures	¥ -3 B	¥ -4 B	¥ -5 B	¥ -8 B	¥ -10 B
Cash dividends paid	¥ -906 M	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Repayment loans	¥ -15 B	¥ -12 B	¥ -8 B	¥ -3 B	¥ -1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -681 M	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Net income	¥ 923 M	¥ 5 B	¥ 6 B	¥ 3 B	¥ 8 B
Purchase of treasury stock	¥ -3 M	¥ -2 M	¥ -1 M	¥ -1 M	¥ -1 M
Other Change in Stockholders Equity	¥ -1 M	¥ -1 M	¥ -2 M	¥ -1 M	¥ -21 M
Other Change in Net Assets	¥ -4 B	¥ 690 M	¥ -4 B	¥ -841 M	¥ 2 B
Net Change in Net Assets	¥ -4 B	¥ 5 B	¥ 963 M	¥ 1 B	¥ 9 B

Financial Indicator Details: The Nippon Synthetic Chemical Industry

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	0.66%	8.18%	6.44%	1.62%	8.47%
C/F margin	-	-	-	-	-
ROA	0.44%	5.74%	4.46%	1.05%	5.66%
ROE	0.80%	9.80%	6.96%	1.69%	8.83%
Recurring margin	1.68%	12.92%	10.17%	5.52%	12.73%
EBIT margin	1.33%	13.09%	10.19%	3.02%	-
EBITDA margin	1.53%	13.27%	10.37%	3.29%	-
NOPAT margin	0.80%	7.85%	6.11%	1.81%	-
Sales SG rates	79.42%	69.24%	70.74%	74.49%	91.52%
Sales SG&A rates	16.79%	17.83%	18.81%	20.02%	-
Sales R&D expenses rates	3.33%	3.86%	4.48%	5.14%	-
Sales depreciation rates	0.20%	0.18%	0.17%	0.26%	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	1.29%	-21.27%	-49.59%	-100.00%
Equity growth	-	8.67%	5.00%	-0.63%	7.84%
Total assets growth	-	1.74%	-4.06%	2.65%	4.47%
Sales growth	-	6.86%	-5.28%	-4.00%	7.73%
Net profit growth	-	1,217.86%	-25.47%	-75.75%	461.14%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	717.50%	-25.43%	-47.82%	148.05%
EBIT growth	-	948.14%	-26.25%	-71.51%	-100.00%
EBITDA growth	-	822.20%	-26.00%	-69.51%	-100.00%
NOPAT growth	-	948.14%	-26.25%	-71.51%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	54.82%	58.56%	64.09%	62.03%	64.04%
Liquidity ratio	171.53%	213.38%	195.80%	161.54%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	87.43%	131.16%	120.15%	91.66%	-
Fixed ratio	49.56%	45.59%	46.62%	51.88%	-
D/E ratio	49.56%	30.45%	17.84%	17.97%	-
Loan to Value Ratio	27.17%	17.83%	11.44%	11.15%	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-33.23%	-38.44%	0.06%	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	42.94day	40.70day	33.83day	17.76day	-
Receivables turnover	67.35day	104.54day	99.67day	112.38day	-
Inventory turnover	79.65day	64.81day	71.83day	85.33day	-
Fixed assets turnover	148.50day	138.94day	157.49day	181.42day	-
Total asset turnover	546.49day	520.32day	527.05day	563.64day	546.60day
Payable turnover	34.34day	49.03day	49.94day	58.29day	-
Capital turnover	116.26day	108.79day	114.87day	119.66day	-
Equity turnover	299.63day	304.70day	337.81day	349.68day	350.05day
Working capita turnover	112.66day	120.32day	121.56day	139.41day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 6 B	¥ 6 B	¥ 5 B	¥ 2 B	-
Accounts receivable-trade	¥ 10 B	¥ 17 B	¥ 15 B	-	-
Other Current Assets	¥ 26 B	¥ 32 B	¥ 28 B	¥ 31 B	-
Current Assets	¥ 33 B	¥ 39 B	¥ 34 B	-	-
Tangible Assets	¥ 22 B	¥ 22 B	¥ 24 B	¥ 27 B	-
Intangible Assets	¥ 424 M	¥ 428 M	¥ 347 M	¥ 339 M	-
Investment etc.	¥ 27 B	¥ 23 B	¥ 23 B	¥ 22 B	¥ 88 B
Total Assets	¥ 84 B	¥ 86 B	¥ 82 B	¥ 84 B	¥ 88 B
Current Liabilities	¥ 19 B	¥ 18 B	¥ 17 B	¥ 21 B	¥ 31 B
Fixed Liabilities	¥ 18 B	¥ 17 B	¥ 12 B	¥ 10 B	-
Liabilities with interest	¥ 22 B	¥ 15 B	¥ 9 B	¥ 9 B	-
Net Assets	¥ 46 B	¥ 50 B	¥ 52 B	¥ 52 B	¥ 56 B
Capital stock	¥ 17 B	¥ 17 B	¥ 17 B	¥ 17 B	-
Capital surplus etc.	¥ 28 B	¥ 32 B	¥ 34 B	¥ 34 B	¥ 56 B
Liabilities and net assets	¥ 84 B	¥ 86 B	¥ 82 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 56 B	¥ 60 B	¥ 57 B	¥ 54 B	¥ 59 B
Cost of Sales	¥ 44 B	¥ 41 B	¥ 40 B	¥ 40 B	¥ 54 B
Gross profit	¥ 11 B	¥ 18 B	¥ 16 B	¥ 13 B	¥ 5 B
Other income	¥ 747 M	¥ 1 B	¥ 661 M	¥ 545 M	-
SG&A	¥ 9 B	¥ 10 B	¥ 10 B	¥ 10 B	-
Other expenses	¥ 2 B	¥ 3 B	¥ 2 B	¥ 2 B	-
Net income	¥ 375 M	¥ 4 B	¥ 3 B	¥ 893 M	¥ 5 B
Operating income	¥ 2 B	¥ 7 B	¥ 5 B	¥ 3 B	¥ 6 B
Ordinary Income	¥ 954 M	¥ 7 B	¥ 5 B	¥ 3 B	¥ 7 B
EBITDA	¥ 869 M	¥ 8 B	¥ 5 B	¥ 1 B	-
Income before income taxes	¥ 681 M	¥ 7 B	¥ 5 B	-	-
Depreciation	¥ 115 M	¥ 111 M	¥ 102 M	¥ 148 M	-
R&D expenses	¥ 1 B	¥ 2 B	¥ 2 B	-	-
Income taxes	¥ 306 M	¥ 2 B	¥ 1 B	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -681 M	¥ -1 B	¥ -1 B	-	-
Net income	¥ 375 M	¥ 4 B	¥ 3 B	-	-
Purchase of treasury stock	¥ -3 M	¥ -2 M	¥ -1 M	-	-
Other Change in Stockholders Equity	-	-	¥ -2 M	¥ 1 M	-
Other Change in Net Assets	¥ -375 M	¥ 152 M	¥ -87 M	-	-
Net Change in Net Assets	¥ -684 M	¥ 4 B	¥ 2 B	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: The Nippon Synthetic Chemical Industry (Annual )

Statement Type

Annual : The Nippon Synthetic Chemical Industry

First quarter : The Nippon Synthetic Chemical Industry

Second quarter : The Nippon Synthetic Chemical Industry

Third quarter : The Nippon Synthetic Chemical Industry

Analysis Menu

Outline : The Nippon Synthetic Chemical Industry

Statement : The Nippon Synthetic Chemical Industry

Rating : The Nippon Synthetic Chemical Industry

Indicator : The Nippon Synthetic Chemical Industry

Download : The Nippon Synthetic Chemical Industry

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
The Nippon Synthetic Chemical Industry	4201	TSE 1st	Chemicals	3	Annual	A

Related Company

キッセイ薬品工業 (Sales ¥ 62 B)

Sekisui Chemical (Sales ¥ 1.0 T)

Fuso Pharmaceutical Industries (Sales ¥ 48 B)

中外製薬 (Sales ¥ 391 B)

Mitsubishi Tanabe Pharma (Sales ¥ 419 B)

Nissan Chemical Industries (Sales ¥ 153 B)

NIPPON KAYAKU (Sales ¥ 128 B)

The Nippon Synthetic Chemical Industry (Sales ¥ 91 B)

TSUMURA & CO. (Sales ¥ 105 B)

キョーリン製薬ホールディングス (Sales ¥ 107 B)

Takeda Pharmaceutical (Sales ¥ 1.5 T)

持田製薬 (Sales ¥ 89 B)

ダイセル (Sales ¥ 358 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .